Early corneal edema following topical application of mitomycin-C

Shu-Wen Chang1

  • 1Department of Ophthalmology, Far Eastern Memorial Hospital, 21 ZSection 2, Nan-Ya South Road, Ban-Chiao, Taipei 220, Taiwan. swchang@mail.femh.org.tw

Abstract

Insights

A single application of mitomycin-C (MMC) causes dose-dependent corneal edema and endothelial apoptosis in rabbits. Further clinical studies are needed to confirm these effects in human eyes.

Area of Science:

  • Ophthalmology
  • Corneal Surgery
  • Ocular Pharmacology

Background:

  • Mitomycin-C (MMC) is used intraoperatively.
  • Its effects on the cornea require further investigation.

Purpose of the Study:

  • To determine the effect of a single intraoperative application of mitomycin-C (MMC) on the cornea.

Main Methods:

  • 63 rabbits underwent mechanical debridement of the central cornea.
  • Corneas were treated with 0.01% or 0.02% MMC solution, or balanced salt solution (control).
  • Corneal thickness, clarity, epithelial defect size, endothelial cell density, and apoptosis were assessed over 14 days.

Main Results:

  • MMC application led to a dose-dependent increase in corneal thickness, decreased clarity, and increased endothelial apoptosis.
  • Endothelial swelling, pleomorphism, and polymegathism were observed, with a dose-dependent decrease in cell density.

Conclusions:

  • A single intraoperative application of MMC induces dose-dependent corneal edema and endothelial apoptosis in a rabbit model.
  • Clinical studies in human eyes are recommended to validate these findings.

Related Concept Videos